Trial Profile
Lamotrigine use in treatment refractory depression in adolescents
Status:
Discontinued
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary) ; Fluoxetine; Sertraline
- Indications Bipolar disorders; Major depressive disorder
- Focus Therapeutic Use
- 16 May 2017 Status changed from suspended to discontinued.
- 08 Oct 2006 New trial record.